Future Health Care Equity ETF (GDOC)
NYSEARCA: GDOC · Real-Time Price · USD
32.76
+0.11 (0.33%)
Dec 23, 2024, 2:25 PM EST - Market closed
1.12% (1Y)
| Assets | $20.36M |
| Expense Ratio | 0.75% |
| PE Ratio | 35.25 |
| Shares Out | 625,000 |
| Dividend (ttm) | $0.01 |
| Dividend Yield | 0.02% |
| Ex-Dividend Date | Dec 23, 2024 |
| Payout Ratio | 19.26% |
| 1-Year Return | +1.12% |
| Volume | 12 |
| Open | 32.19 |
| Previous Close | 32.31 |
| Day's Range | 32.19 - 32.76 |
| 52-Week Low | 32.19 |
| 52-Week High | 37.23 |
| Beta | 0.87 |
| Holdings | 41 |
| Inception Date | Nov 9, 2021 |
About GDOC
Fund Home PageThe Future Health Care Equity ETF (GDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to equities of companies that are driving innovation in healthcare globally. GDOC was launched on Nov 9, 2021 and is issued by Goldman Sachs.
Top 10 Holdings
57.07% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.62% |
| Boston Scientific Corporation | BSX | 7.78% |
| Intuitive Surgical, Inc. | ISRG | 6.03% |
| UnitedHealth Group Incorporated | UNH | 5.91% |
| Insulet Corporation | PODD | 5.81% |
| AbbVie Inc. | ABBV | 5.74% |
| Merck & Co., Inc. | MRK | 4.20% |
| The Cooper Companies, Inc. | COO | 4.17% |
| Abbott Laboratories | ABT | 4.06% |
| Novo Nordisk A/S | NOVO.B | 3.75% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2024 | $0.006 | n/a |
| Dec 26, 2023 | $0.179 | Jan 2, 2024 |
| Sep 26, 2022 | $0.00003 | Sep 30, 2022 |
News
Goldman Sachs is building on the disruptive investing theme with a trio of new ETFs
Goldman Sachs Group is offering investors new ways to seek equity gains from disruptive companies, with its asset management business launching three exchange-traded funds focused on secular growth tr...
3 years ago - Market Watch